iCAD Reports Fourth Quarter And Full-Year 2017 Financial Results
Fourth quarter total revenues
increased 14% year-over-year; total revenues
increased 22% excluding MRI asset sale
Conference call today
at 4:30 p.m. ET
NASHUA, N.H. (March 22, 2018) – iCAD, Inc. (NASDAQ: ICAD), an industry-leading
provider of advanced image analysis, workflow solutions and radiation therapy
for the early identification and treatment of cancer, today reported financial
results for the three and twelve months ended December 31, 2017.